FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1962175162> ?p ?o ?g. }

• W1962175162 endingPage "1208" @default.
• W1962175162 startingPage "1200" @default.
• W1962175162 abstract "A total of 304 patients with limited small-cell carcinoma of the lung were treated with a combination of cyclophosphamide, Adriamycin (Adria Laboratories, Columbus, Ohio), and vincristine (CAV) and elective brain irradiation (3,600 rad TD in 14 fractions). The patients were randomized to either receive or not receive thoracic irradiation (4,000 rad TD, split course). Of the 304 patients, 291 were eligible for the study. Two hundred eighteen (75%) were completely evaluable. In each group, 81% of the patients had a Karnofsky index of 80% or higher and 14% had supraclavicular or scalene lymph nodes. Patients treated with CAV and no thoracic irradiation had a complete response (CR) of 48%, in contrast to 63% for those receiving chest irradiation (P = .05). In the first group, the complete and partial response rate was 70%; in the second, 80%. The median survival for the eligible patients treated with CAV and brain radiation therapy was 49 weeks; for those treated with the same regimen plus thoracic irradiation, the median survival was 60 weeks. The actuarial two-year tumor-free survival is 19% in the first group and 28% in the second group. The median survival for the responders in the CAV plus brain irradiation group was 57 weeks and for those receiving thoracic irradiation, 78 weeks (P = .12). Thoracic failure was 52% in patients not treated with thoracic radiation therapy v 36% in those receiving it (P = .06). The distant metastases incidence was 23% in patients not treated with thoracic radiation and 35% in patients treated with thoracic radiation. Hematologic toxicity was comparable in both groups; 30% of the patients had moderate to severe granulocytopenia and 6%, low homoglobin. Two toxicity-related deaths occurred (one in each group). Moderate gastrointestinal toxicity was noted in 41% and severe in 16% of the patients receiving CAV and brain irradiation without thoracic radiotherapy v 44% and 20% in those irradiated in the thorax. Disease-free survival is enhanced in the patients receiving thoracic irradiation. More effective chemotherapy is critically needed to significantly improve overall survival. These preliminary results suggest that thoracic irradiation should be a primary component in the therapy of these patients, although this combined therapy is moderately toxic.(ABSTRACT TRUNCATED AT 400 WORDS)" @default.
• W1962175162 created "2016-06-24" @default.
• W1962175162 creator A5007018215 @default.
• W1962175162 creator A5010043335 @default.
• W1962175162 creator A5032962015 @default.
• W1962175162 creator A5038188856 @default.
• W1962175162 creator A5038399837 @default.
• W1962175162 creator A5048660181 @default.
• W1962175162 creator A5057623456 @default.
• W1962175162 creator A5060036184 @default.
• W1962175162 creator A5073724595 @default.
• W1962175162 creator A5078808057 @default.
• W1962175162 date "1984-11-01" @default.
• W1962175162 modified "2023-09-26" @default.
• W1962175162 title "Randomized trial of radiotherapy to the thorax in limited small-cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: a preliminary report." @default.
• W1962175162 cites W1971979169 @default.
• W1962175162 cites W1974407877 @default.
• W1962175162 cites W1977588867 @default.
• W1962175162 cites W1979300931 @default.
• W1962175162 cites W2001824406 @default.
• W1962175162 cites W2009883621 @default.
• W1962175162 cites W2020951343 @default.
• W1962175162 cites W2022660788 @default.
• W1962175162 cites W2034553767 @default.
• W1962175162 cites W2036050882 @default.
• W1962175162 cites W2052260064 @default.
• W1962175162 cites W2066923265 @default.
• W1962175162 cites W2071451577 @default.
• W1962175162 cites W2098415065 @default.
• W1962175162 cites W2130234637 @default.
• W1962175162 cites W2137201447 @default.
• W1962175162 cites W2143594378 @default.
• W1962175162 cites W2166418980 @default.
• W1962175162 cites W2274235404 @default.
• W1962175162 cites W2405391497 @default.
• W1962175162 cites W2410902949 @default.
• W1962175162 cites W2412526696 @default.
• W1962175162 cites W2413770114 @default.
• W1962175162 cites W2414007740 @default.
• W1962175162 cites W2414827784 @default.
• W1962175162 cites W2418513986 @default.
• W1962175162 cites W2439714069 @default.
• W1962175162 cites W2469446424 @default.
• W1962175162 doi "https://doi.org/10.1200/jco.1984.2.11.1200" @default.
• W1962175162 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6092555" @default.
• W1962175162 hasPublicationYear "1984" @default.
• W1962175162 type Work @default.
• W1962175162 sameAs 1962175162 @default.
• W1962175162 citedByCount "193" @default.
• W1962175162 countsByYear W19621751622012 @default.
• W1962175162 countsByYear W19621751622013 @default.
• W1962175162 countsByYear W19621751622014 @default.
• W1962175162 countsByYear W19621751622017 @default.
• W1962175162 countsByYear W19621751622021 @default.
• W1962175162 crossrefType "journal-article" @default.
• W1962175162 hasAuthorship W1962175162A5007018215 @default.
• W1962175162 hasAuthorship W1962175162A5010043335 @default.
• W1962175162 hasAuthorship W1962175162A5032962015 @default.
• W1962175162 hasAuthorship W1962175162A5038188856 @default.
• W1962175162 hasAuthorship W1962175162A5038399837 @default.
• W1962175162 hasAuthorship W1962175162A5048660181 @default.
• W1962175162 hasAuthorship W1962175162A5057623456 @default.
• W1962175162 hasAuthorship W1962175162A5060036184 @default.
• W1962175162 hasAuthorship W1962175162A5073724595 @default.
• W1962175162 hasAuthorship W1962175162A5078808057 @default.
• W1962175162 hasConcept C105702510 @default.
• W1962175162 hasConcept C121608353 @default.
• W1962175162 hasConcept C126322002 @default.
• W1962175162 hasConcept C141071460 @default.
• W1962175162 hasConcept C168563851 @default.
• W1962175162 hasConcept C2776694085 @default.
• W1962175162 hasConcept C2776755627 @default.
• W1962175162 hasConcept C2777546739 @default.
• W1962175162 hasConcept C2777714996 @default.
• W1962175162 hasConcept C2779013556 @default.
• W1962175162 hasConcept C2779223589 @default.
• W1962175162 hasConcept C2779562246 @default.
• W1962175162 hasConcept C2989005 @default.
• W1962175162 hasConcept C45393284 @default.
• W1962175162 hasConcept C500558357 @default.
• W1962175162 hasConcept C509974204 @default.
• W1962175162 hasConcept C71924100 @default.
• W1962175162 hasConcept C97834683 @default.
• W1962175162 hasConceptScore W1962175162C105702510 @default.
• W1962175162 hasConceptScore W1962175162C121608353 @default.
• W1962175162 hasConceptScore W1962175162C126322002 @default.
• W1962175162 hasConceptScore W1962175162C141071460 @default.
• W1962175162 hasConceptScore W1962175162C168563851 @default.
• W1962175162 hasConceptScore W1962175162C2776694085 @default.
• W1962175162 hasConceptScore W1962175162C2776755627 @default.
• W1962175162 hasConceptScore W1962175162C2777546739 @default.
• W1962175162 hasConceptScore W1962175162C2777714996 @default.
• W1962175162 hasConceptScore W1962175162C2779013556 @default.
• W1962175162 hasConceptScore W1962175162C2779223589 @default.
• W1962175162 hasConceptScore W1962175162C2779562246 @default.
• W1962175162 hasConceptScore W1962175162C2989005 @default.
• W1962175162 hasConceptScore W1962175162C45393284 @default.
• W1962175162 hasConceptScore W1962175162C500558357 @default.

• next